Financhill
Buy
70

HUBB Quote, Financials, Valuation and Earnings

Last price:
$456.11
Seasonality move :
1.83%
Day range:
$452.32 - $460.40
52-week range:
$299.43 - $484.26
Dividend yield:
1.18%
P/E ratio:
28.30x
P/S ratio:
4.31x
P/B ratio:
6.59x
Volume:
117.1K
Avg. volume:
488.7K
1-year change:
5.61%
Market cap:
$24.2B
Revenue:
$5.6B
EPS (TTM):
$16.12

Earnings Data

Next earnings date for HUBB
Feb 03
2026
Most recent earnings per share
$4.78
Missed by $0.20
(Oct 28/2025)
Consensus Estimate
$4.98
(Oct 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HUBB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/03/2026 Q4 $1.5B -- -- $4.72 --
10/28/2025 Q3 $1.5B $1.5B $4.78 $4.98 -$0.20
07/29/2025 Q2 $1.5B $1.5B $4.56 $4.40 $0.16
05/01/2025 Q1 $1.4B $1.4B $3.15 $3.72 -$0.58
02/04/2025 Q4 $1.4B $1.3B $3.64 $4.02 -$0.38
10/29/2024 Q3 $1.5B $1.4B $4.18 $4.46 -$0.28
07/30/2024 Q2 $1.5B $1.5B $4.01 $4.21 -$0.20
04/30/2024 Q1 $1.4B $1.4B $2.73 $3.55 -$0.82
01/30/2024 Q4 $1.3B $1.3B $3.16 $3.58 -$0.42
10/31/2023 Q3 -- $1.4B $3.70 -- --
07/25/2023 Q2 -- $1.4B $3.82 -- --
04/25/2023 Q1 -- $1.3B $3.37 -- --
01/31/2023 Q4 -- $1.2B $1.93 -- --
10/25/2022 Q3 -- $1.3B $2.57 -- --
07/26/2022 Q2 -- $1.3B $2.51 -- --
04/26/2022 Q1 -- $1.2B $3.30 -- --
02/03/2022 Q4 -- $1.1B $2.14 -- --
10/26/2021 Q3 -- $1.1B $1.98 -- --
07/27/2021 Q2 -- $1.1B $1.75 -- --
04/27/2021 Q1 -- $956.3M $1.42 -- --
02/02/2021 Q4 -- $917.1M $1.48 -- --
10/27/2020 Q3 -- $1.1B $1.96 -- --
07/30/2020 Q2 -- $949M $1.62 -- --
04/30/2020 Q1 -- $1.1B $1.37 -- --
02/04/2020 Q4 -- $1.1B $1.86 -- --
10/29/2019 Q3 -- $1.2B $2.38 -- --
07/30/2019 Q2 -- $1.2B $1.75 -- --
04/30/2019 Q1 -- $1.1B $1.32 -- --
02/05/2019 Q4 -- $1.1B $1.60 -- --
10/23/2018 Q3 -- $1.2B $2.06 -- --
07/24/2018 Q2 -- $1.2B $1.82 -- --
04/24/2018 Q1 -- $991.2M $1.05 -- --
01/30/2018 Q4 -- $918M $0.37 -- --
10/24/2017 Q3 -- $950.7M $1.47 -- --
07/25/2017 Q2 -- $948.3M $1.43 -- --
04/25/2017 Q1 -- $852.3M $1.13 -- --
01/17/2017 Q4 -- $854.3M $1.15 -- --
10/25/2016 Q3 -- $907.4M $1.56 -- --
07/26/2016 Q2 -- $909.1M $1.45 -- --
04/26/2016 Q1 -- $834.7M $1.07 -- --
01/28/2016 Q4 -- $829.7M $1.06 -- --

Hubbell, Inc. Earnings Questions

  • How Much did Hubbell, Inc. Generate in Revenue Last Quarter?

    Hubbell, Inc. reported $1.5B worth of top line sales in its most recent quarter.

  • Did Hubbell, Inc. Beat Earnings Last Quarter?

    Hubbell, Inc. announced earnings per share of $4.78 which represents a miss of analyst forecast a $4.98 per share.

  • Is Hubbell, Inc. Profitable?

    Hubbell, Inc. reported $548.2M that represents $10.27 per share over the last quarter.

  • What is the Analyst Consensus for Hubbell, Inc. EPS Next Year?

    Hubbell, Inc.'s earnings are forecast to grow from $14.38 per share to $16.41 per share next year representing an increase of 26.5%.

  • When is Hubbell, Inc.'s Earnings Date?

    Hubbell, Inc.'s next earnings date is February 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock